Goldman Sachs logo
Goldman Sachs

May 14, 2026

Key Takeaways From Meetings With TFC Management

Single Stock ReportEquitiesRates CreditFinancials

Truist Financial is executing a strategy to reach a 16-18% ROTCE by 2027-2029 through NIM expansion, aggressive capital returns, and fee income growth in core business lines. Goldman Sachs maintains a Buy rating with a $58 price target based on confidence in these management targets.

Key Takeaways

  • 1.Truist expects to achieve a 15% ROTCE in 2027 and a medium-term target of 16-18% through ROA improvement and capital efficiency.
  • 2.Net Interest Income (NII) growth through 2026 is anticipated to be driven by fixed-rate asset repricing and optimization of the deposit mix.
  • 3.Management is prioritizing ROTCE-accretive loan growth in commercial and specialty consumer segments while rotating out of lower-return portfolios like indirect auto.

Table of Contents

  • Key takeaways from meetings with management
  • NIM improvements expected through the year to help drive 2H NII growth
  • Looking for return to accretive commercial and consumer growth with a focus on full wallet relationships
  • Targeting payments-led commercial deposit growth with a focus on deepening in consumer
  • Looking for sustained to accelerating growth in each of its priority fee categories over time to reach 16-18% ROTCE
  • Expecting continued positive operating leverage, with expense efficiencies helping to offset investments
  • Commercial and consumer credit quality remains solid
  • Robust capital return on the way to 10%; CET1 optimization opportunities through RWA density
  • Improving quality of revenue growth as well as lower CET1 to drive 16-18% ROTCE
  • Revenue and efficiency opportunities from AI
  • Key takeaways from meetings with Head of Consumer Lending, Head of Commercial and Corporate Banking, and Chairman and CEO of Truist Securities
  • Valuation and risks

Document Preview

Page 1 of 5
Page 1 of Key Takeaways From Meetings With TFC Management
Subscribe for full access

Access the Full Report

Get unlimited access to institutional research reports with a 14-day free trial.